Author

Tina Lehmann

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Advitiya Khandelwal· 1 shared Andreas RosenwaldiD· 1 shared Anita Cindric Vranesic· 1 shared Björn von EyßiD· 1 shared Cagla Dönmez· 1 shared Celina Junker· 1 shared Christin Ritter· 1 shared Donato InversoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Advitiya Khandelwal

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Transient YAP/TAZ inhibition exposes therapeutic vulnerabilities in advanced cancers

Marco Jessen, KyungMok Kim, Marie Tollot, Anita Cindric Vranesic, Cagla Dönmez, Celina Junker, Tina Lehmann, Advitiya Khandelwal, Yuliya V. Kurlishchuk, Tom Hünniger, Christin Ritter, Evaristo Di Napoli, Shyam Krishnan Murali, Viktoria Buck, Sabine Muth, , Björn von Eyß

This study shows that transient YAP/TAZ inhibition can suppress tumor growth in advanced cancers and enhances immunotherapy when combined with immune checkpoint blockade.

bioRxiv · Jul 3, 2025 · PreprintCancer Biology